Meas, T <br/><br/>
Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.  [electronic resource] 

 -  European journal of internal medicine  Mar 2009 
 - 197-200 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1879-0828 
<br/><br/><label>Standard No.: </label>10.1016/j.ejim.2008.06.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Atorvastatin<br/>Cholesterol, HDL--blood<br/>Cholesterol, LDL--blood<br/>Clofibric Acid--administration & dosage<br/>Diabetes Mellitus, Type 2--blood<br/>Dyslipidemias--blood<br/>Female<br/>Follow-Up Studies<br/>Heptanoic Acids--administration & dosage<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--administration & dosage<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Pyrroles--administration & dosage<br/>Triglycerides--blood